Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilars: US FDA Asked To Clarify Thinking On Pediatric Studies, Indication Carve-Outs

Feb 22 2019

• By Sue Sutter

Arrows miss target

Related Content

When Drugs Become Biologics: US FDA Guidances Explain 'Transition Provisions'

Dec 11 2018

US Biosimilars: FDA Seeks To Build On Record Number Of Approvals, But Shutdown May Blunt Progress

Jan 23 2019

NORD Slams Orphan Indication Discussion At Biosimilar Advisory Committee

Feb 15 2016

Related Companies

Pfizer Inc.

Johnson & Johnson

Celltrion, Inc.

Novartis AG

Novartis AG

Additional Topics

United States Biosimilars Pediatrics Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window